Lilituf Cream contains Luliconazole 1% w/w, a topical antifungal agent indicated for the treatment of superficial fungal infections of the skin, including dermatophytosis, candidiasis, and pityriasis versicolor. Luliconazole is an imidazole derivative that exerts its antifungal effect by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Lilituf Cream is effective against a broad spectrum of dermatophytes such as Trichophyton rubrum and Trichophyton mentagrophytes, as well as Candida species and Malassezia furfur. The cream is intended for external use and should be applied once daily to the affected area after cleansing and drying the skin. Treatment duration typically ranges from one to two weeks depending on the severity and type of infection. Lilituf Cream is generally well tolerated; however, mild local adverse reactions such as burning, itching, or irritation may occur. It is contraindicated in individuals with known hypersensitivity to luliconazole or any cream excipients. Patients are advised to avoid contact with eyes and mucous membranes and to discontinue use if severe irritation develops. Lilituf Cream offers a convenient and effective option for managing common superficial fungal infections.